Literature DB >> 10319021

Encephalomyocarditis (EMC) virus infection in PC12 and C6 cells.

W Su1, A Ueno-Yamanouchi, H Nakayama, K Doi.   

Abstract

PC12 cells derived rom rat pheochromocytoma and C6 cells derived from rat glioma were infected with 0.3 plaque forming units (PFU)/cell of the D variant of encephalomyocarditis virus (EMC-D), after pretreatment with or without nerve growth factor (NGF). The virus titres in medium and cells were investigated at 6, 12, 24, 48 and 72 h post infection (HPI), and histopathology and viral antigens in cells were examined at 24 and 48 HPI, respectively. As a result, neither viral replication nor light and electron microscopic changes were observed in PC12 cell cultures without NGF-pretreatment. On the contrary, in PC12 cell cultures with NGF-pretreatment, the virus titre prominently increased at 12 HPI, and peaked at 48 HPI. In addition, distinct histological and ultrastructural changes with viral antigens in cells were observed. C6 cells showed similar morphology and susceptibility to EMC-D-infection irrespective of NGF-pretreatment. Namely, the virus titres in C6 cell cultures increased slightly and viral antigens were found in a small number of C6 cells, but there were no evident histological and ultrastructural changes. These results suggest that PC12 cells pretreated with NGF and C6 cells are susceptible to EMC-D infection in vitro.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10319021      PMCID: PMC3220366          DOI: 10.1046/j.1365-2613.1998.00077.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  2 in total

1.  Age-related changes in susceptibility of rat brain slice cultures including hippocampus to encephalomyocarditis virus.

Authors:  W Su; A Ueno-Yamanouchi; K Uetsuka; H Nakayama; K Doi
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

2.  A novel lymphocyte signaling defect: trk A mutation in the syndrome of congenital insensitivity to pain and anhidrosis (CIPA).

Authors:  I Melamed; J Levy; R Parvari; E W Gelfand
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.